Abstract
Interferon (IFN) modulates the expression of several genes and some of themare considered to be responsible for the inhibition of cellular growth. However, the alterations of cell cycle-regulating genes produced by IFN still remain unclear. Accordingly, we studied the expression of cell cycle-regulating genes during IFN-induced growth arrest. Cell cycle synchronized and unsynchronized Daudi Burkitt lymphoma cells were treated with IFN. Both the cell cycle distribution and the expression of cell cycle-regulating genes (cdk2, cdc2, cyclins A, B, C, D3 cdc25, and well) were studied by flow cytometry and by Northern blot hybridization or the reverse-transcription polymerase chain reaction, respectively. Treated cells passed through the first G1 phase and gradually accumulated in the following G1 phase. Expression of cyclins A, B, and D3 oscillated along with the cell cycle progression in control cells, and the alterations of cyclin B expression were especially prominent. Both cdc2 and cdk2 also showed changes, but these were not so distinct as observed with cyclin B. Expression of cdc25 and weel was little affected by cell cycle progression. In IFN-treated cells, expression of cyclins A and B were down-regulated, while that of cyclin C was not. Cyclin D3 expression was also down-regulated at 48 h, followed by an increase at 72 h. Expression of both cdc2 and cdk2 was down-regulated, especially that of the later. Weel expression was down-regulated by IFN but, the expression of cdc25 remained stable. These findings suggest that the modulation of cell cycle-regulating genes, particular by cyclin A and cdk2, plays an important role in IFN-induced cellular growth arrest.
Similar content being viewed by others
References
Clemens MJ, McNurlan MA: Regulation of cell proliferation and differentiation by interferons. Biochem J 226: 345–360, 1985
Meurs E, Chong K, Galabru J, Thomas NSB, Kerr IM, Williams BRG, Hovanessian AG: Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62: 379–390, 1990
Thomis DC, Samuel CE: Mechanism of interferon, action: Autoregulation of RNA-dependent P1/e1F-2α protein kinase (PKR) expression in transfected mammalian cells. Proc Natl Acad Sci USA 89: 10837–10841, 1992
Meurs EF, Galabru J, Barber GN, Katze MG, Hovanessian AG: Tumor suppresser function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 90: 232–236, 1993
Uzé G, Lutfalla G, Gresser I: Genetic transfer of a functional human interferon α receptor into mouse cells: Cloning and expression of its cDNA. Cell 60: 225–234, 1990
Pfeffer LM, Tan YH: Do second messengers play a role in interferon signal transduction? TIBS 16: 321–323, 1991
Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T, Taniguchi T: Structually, similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58: 729–739, 1989
Tanaka T, Kawakami T, Taniguchi T: Recognition DNA sequence of interferon regulatory factor (IRF-1) and IRF-2, regulatory of cell growth and the interferon system. Mol Cell Biol 13: 4531–4538, 1993
Sherr CJ: Mammalian G1 cyclins. Cell 73: 1059–1065, 1993
Bandara LR, Adamczewski JP, Hunt T, Thangue NBL: Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature 352: 249–251, 1991
Shirodkar S, Ewen M, DeCaprio JA, Morgan J, Livingston DM, Chittenden T: The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68: 157–166, 1992
Pagano M, Draetta G, Jansen-Durr P: Association of cdk2 kinase with the transcription factor E2F during S phase. Science 255: 1144–1147, 1992
Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G: Cyclin A is required at two points in the human cell cycle. The EMBO J 11: 961–971, 1992
Devoto S, Madryj M, Pines J, Hunter T, Nevins JR: A cyclin A-protein kinase complex processes sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex. Cell 68: 167–176, 1992
Nurse P: Universal control mechanism regulating onset of M-phase. Nature 344: 503–508, 1990
Mirray AW: Creative blocks: cell-cycle checkpoints and feedback controls. Nature 359: 599–604, 1992
Millar JBA, Russell P: The cec25 M-phase inducer: An unconventional protein phosphatase. Cell 68: 407–410, 1992
Yamada H, Shimoyama M: Growth inhibitory activity of human lymphoblastoid and fibroblast interferonsin vitro. Gann 74: 299–307, 1983
Roos G, Leanderson T, Lundgren E: Interferon-induced cell cycle changes in human hematopoietic cell lines and fresh leukemic cells. Cancer Res 44: 2358–2362, 1984
Einat M, Resnitzky D, Kimchi A: Close link between reduction of c-myc expression by interferon and G0/G1 arrest. Nature 313: 597–600, 1985
Resnitzky D, Tiefenbrun N, Berrisi H, Kimch A: Interferons and interleukin-6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Proc Natl Acad Sci USA 89: 402–406, 1992
Maniatis T, Fritsch EF, Sambrook J: Molecular cloning: A laboratory manual. Clod Spring Harbor Laboratory, New York, 1982, pp 187–210
Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Molec Biol 98: 503–517, 1975
Yamada H, Sakamoto H, Taira M, Nishimura S, Shimosato Y, Terada M, Sugimura S: Amplification of both C−Ki-ras with a point mutation and c-myc in a primary pancreatic cancer and its metastatic tumors in lymph nodes. Jpn J Cancer Res (Gann) 77: 370–375, 1986
Ninomiya-Tsuji J, Nomoto S, Yasuda H, Reed SI, Matsumoto K: Cloning of a human cDNA encoding a CDC2-related kinase by complementation of a budding yeast cdc28 mutation. Proc Natl Acad Sci USA 88: 9006–9010, 1991
Pines J, Hunter T: Human cyclic A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature 346: 760–763, 1990
Lew DJ, Dulic V, Reed SI: Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 66: 1197–1206, 1991
Lee MG, Nurse P: Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2. Nature 327: 31–35, 1987
Pines J, Hunter T: Isolation of a human cyclin cDNA: Evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 58: 833–846, 1989
Nagata A, Igarashi M, Jinno S, Suto K, Okayama H: An additional homolog of the fission yeast cdc25+ gene occurs in humans and is highly expressed in some cancer cells. The New Biologist 3: 959–968, 1991
Igarashi M, Nagata A, Jinno S, Suto K, Okayama H: Weel+-like gene in human cells. Nature 353: 80–83, 1991
Inaba T, Matsushime H, Valentine M, Roussel MF, Sherr CJ, Look AT: Genomic organization, chromosomal location, and independent expression of human cyclin D genes. Genomics 13: 565–574, 1992
MacGowan CH, Russell P: Human Weel kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr 15. The EMBO J 12: 75–85, 1993
Paker LL, Atherton-Fessler S, Piwnica-Worms H: p107weel is a dualspecificity kinase that phosphorylates p34cdc2 on tyrosine 15. Proc Natl Acad Sci USA 89: 2917–2921, 1992
Horiguchi-Yamada J, Yamada H: Differing responses of G2-related genes during differentiation of HL60 cells induced by TPA or DMSO. Mol Cell Biochem 119: 29–34, 1993
Rowley R, Hudson J, Young PG: The weel protein kinase is required for radiation-induced mitotic delay. Nature 356: 353–355, 1992
Heald R, McLoughlin M, McKeon F: Human weel maintains mitotic timing by protecting the nucleus from cytoplasmically activated cdc2 kinase. Cell 74: 463–474, 1993
Lin BT, Gruenwald S, Morla AO, Lee W, Wang JY: Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. The EMBO J 10: 857–864, 1991
Lees JA, Buchkovich KJ, Marshak DR, Anderson CW, Harlow E: The retinoblastoma protein is phosphorylated on multiple, sites by human cdc2. The EMBO J 10: 4279–4290, 1991
DeCaprio JA, Ludolw JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang CH, Livingston DM: The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58: 1085–1095, 1989
Chen P, Scully P, Shew J, Wang JYJ, Lee W: Phosphorylation of the retinoblastoma gene product is modulated, during the cell cycle and cellular differentiation. Cell 58: 1193–1198, 1989
Mihara K, Cao X, Yen A, Chandler S, Driscoll B, Murphree AL, T'Ang A, Fung YT: Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246: 1300–1303, 1989
Goodrich DW, Wang NP, Qian Y, Lee E, Lee W: The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67: 293–302, 1991
Matsushime H, Roussel MF, Ashmun RA, Sherr CJ: Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65: 701–713, 1991
Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM: Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73: 487–497, 1993
Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA: Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73: 499–511, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamada, H., Ochi, K., Nakada, S. et al. Changes of cell cycle-regulating genes in interferon-treated Daudi cells. Mol Cell Biochem 136, 117–123 (1994). https://doi.org/10.1007/BF00926071
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00926071